AnaptysBio
Dr. Lizzul joined AnaptysBio in July 2020 and leads the company’s development organization, including clinical medicine, clinical operations, regulatory affairs, pharmacology and toxicology functions.
AnaptysBio
3 followers
AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation.